BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10198799)

  • 1. Anthrax vaccine. Model of a response to the biologic warfare threat.
    Nass M
    Infect Dis Clin North Am; 1999 Mar; 13(1):187-208, viii. PubMed ID: 10198799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus anthracis: medical issues of biologic warfare.
    Ibrahim KH; Brown G; Wright DH; Rotschafer JC
    Pharmacotherapy; 1999 Jun; 19(6):690-701. PubMed ID: 10391414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
    Friedlander AM; Pittman PR; Parker GW
    JAMA; 1999 Dec; 282(22):2104-6. PubMed ID: 10591317
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioterrorism. DOD retreats on plan for anthrax vaccine.
    Marshall E
    Science; 2000 Jul; 289(5478):382-3. PubMed ID: 10939944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The controversial anthrax vaccine.
    Goldstein R
    Nurs Spectr (Wash D C); 1999 Jun; 9(11):20-1. PubMed ID: 10562219
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Military stays in Bosnia; vaccinates for anthrax.
    Gunby P
    JAMA; 1998 Jan; 279(4):260-1. PubMed ID: 9450696
    [No Abstract]   [Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Surveillance for adverse effects associated with anthrax vaccination--US Department of Defense, 1998-2000.
    JAMA; 2000 May 24-31; 283(20):2648-9. PubMed ID: 10847805
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax vaccination is based on medical evidence.
    Blanck RR
    Am J Public Health; 2000 Aug; 90(8):1326-7. PubMed ID: 10937023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mixed vaccine against bacterial anthrax and symptomatic anthrax].
    Blancou JM
    Rev Elev Med Vet Pays Trop; 1974; 27(2):183-7. PubMed ID: 4219888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of anthrax or black fever].
    Chantal J
    Med Trop (Mars); 1997; 57(3 Suppl):52-60. PubMed ID: 9513179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation for emergency relief after biological warfare.
    Steffen R; Mellin J; Woodall JP; Rollin PE; Lang RH; Lüthy R; Waldvogel A
    J Infect; 1997 Mar; 34(2):127-32. PubMed ID: 9138135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax: the disease in relation to vaccines.
    Cameron J
    Vaccine; 1984 Dec; 2(4):237. PubMed ID: 6442501
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardization of the seeding material in producing live anthrax vaccine].
    Gladus MA; Nikolaenko IuP; Lazareva ES; Fatkhinurova TI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep; (9):42-6. PubMed ID: 106609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of an improved, human anthrax vaccine.
    Ivins BE; Welkos SL
    Eur J Epidemiol; 1988 Mar; 4(1):12-9. PubMed ID: 3128450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extraction and study of anthrax protective antigen. III. Improvement in the method of obtaining chemical anthrax vaccine under laboratory conditions].
    Debrin MI; Kuz'mich MK; Garin NS; Tarumov VS; Mikhaĭlov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):63-7. PubMed ID: 404807
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax vaccines.
    Friedlander AM; Welkos SL; Ivins BE
    Curr Top Microbiol Immunol; 2002; 271():33-60. PubMed ID: 12224523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.